A NEW TRADE IDEA: BIOTECH COMPANY MAY HAVE A CURE FOR THE CANCER THAT KILLED APPLE’S STEVE JOBS $AAAP $AAPL $IBB $LABD $XBI $LABU
I’m constantly exposed to speculative biotechnology companies with promising treatments. But few pass our investing screens. Advanced Accelerator Applications SA AAAP, a 15-year-old French radiopharmaceutical company, has been getting a lot of publicity. The company claims to be close to bringing to market a therapy that targets the cancer that killed Apple Inc. AAPL, founder Steve Jobs: an unusual form of pancreatic cancer known as a neuroendocrine tumor or islet cell carcinoma. The company, which has a market value of $1.6 billion, has other therapies in the pipeline and also a diagnostics business. Advanced Accelerator Applications’ latest quarterly report showed